Phase 2 Study to Evaluate an Oral Drug to Treat MS-related Spasticity and Cramps
News
Flex Pharma, Inc., announced the start of a Phase 2 clinical trial assessing the safety and efficacy of FLX-787 in multiple sclerosis (MS) patients who suffer from cramps, spasms, and/or spasticity ... Read more